8 Real Ways to Get Semaglutide Without Insurance in 2026

How much does semaglutide actually cost without insurance right now?

Semaglutide isn't one price, it's three separate tracks wearing the same molecule. Compounded semaglutide, made by a licensed pharmacy for you specifically, is the cheapest track: roughly $150 to $300 a month all-in. Brand-name Wegovy, the FDA-approved version built for obesity, has a manufacturer self-pay program that undercuts retail dramatically once you find it. Ozempic, the same molecule, approved for type 2 diabetes rather than obesity, runs its own pricing ladder, and it's typically the priciest of the three unless you have a diabetes diagnosis backing it.

The number that shows up in headlines, $1,349 a month for Wegovy, closer to $1,000 for Ozempic, is the list price. It's the anchor insurers negotiate against, not what a cash-pay patient actually hands over. Nearly every path below beats that number by a wide margin. The real question isn't brand versus compounded in the abstract; it's which door gets you the lowest verified price for the form you're willing to use.

If my insurance denied it — am I stuck paying more than someone with no insurance at all?

This is the question that actually drives most of the anxiety, so it's worth answering precisely. Novo Nordisk runs two separate Wegovy programs, and which one you land in depends on whether your plan covers the drug, not on whether you have insurance in the first place.

• Your plan covers Wegovy: you're eligible for the Commercial Copay Savings Offer, capped around $25 a month for eligible patients.
• Your plan doesn't cover Wegovy, denied, excluded from your formulary, or you never checked: you use the Self-Pay Offer, the same program a fully uninsured woman uses.
• No insurance at all: identical Self-Pay Offer, identical pricing ladder.
• There is no third, marked-up tier reserved for 'has insurance but it said no.' You fall into the general self-pay track alongside everyone without coverage.

That's genuinely reassuring if a denial letter left you assuming retail was your only option now. It isn't. And there's a biological reason this whole conversation matters more in your forties than it did at thirty: declining estrogen during perimenopause worsens insulin sensitivity and pushes fat distribution toward the abdomen, independent of what you're eating or how much you're moving. It also blunts the same GLP-1 signaling pathway that semaglutide mimics, which is part of why this class of medication has become a genuine clinical option for midlife weight change, not just a generic weight-loss drug that happens to be trending. For the fuller clinical picture, see GLP-1 and menopause.

What's the cheapest legitimate way to get semaglutide without insurance?

If brand-name Wegovy isn't a hard requirement for you, compounded semaglutide from a reputable telehealth provider is consistently the lowest all-in price, and it's where most of the real cash-pay savings live. Four providers are worth pricing against each other directly.

Alloy Health — cheapest all-in price, and the one built for perimenopause specifically

Alloy's compounded semaglutide runs $70 a month for the medication plus $99 a month for its Weight Care membership, $169 all-in. That membership isn't just an access fee: it buys unlimited messaging with a physician who specializes in menopause care, wellness check-ins, dose adjustments, and side-effect management folded into one relationship. For a woman navigating both hormonal change and weight gain at the same time, having one clinician who treats both isn't a minor convenience, it's the whole point. Alloy also prescribes hormone therapy, so if you haven't yet had the HRT conversation alongside a GLP-1 one, it's the rare platform built to have both in the same visit.

The trade-off is geography. Alloy currently isn't available in Alabama, Arkansas, California, Nevada, Louisiana, Mississippi, or DC. If you're in one of those states, move down the list to Mochi or Fridays.

Mochi Health — flat pricing in all 50 states

Mochi charges a flat $99 a month for the medication no matter what dose you're titrated to, plus a $79 monthly membership, $178 all-in. For someone who expects to end up at a higher maintenance dose, that flatness matters: a competitor charging less at the starting dose can end up costlier a few months in, once dose escalation kicks in. Mochi is also one of the few programs with genuine 50-state coverage, which makes it the natural fallback if you're in one of the states Alloy doesn't serve.

Fridays — the cheapest number on the page, if you can commit to a year

Fridays bundles medication, provider visits, dietitian coaching, and shipping into one monthly rate with no separate membership charge. Month-to-month, that's $249. Prepay for a year and it drops to $150 a month, the single lowest monthly figure among the four compounded options here. The honest caveat: that rate requires paying upfront, and Fridays' complaint history shows a pattern around refund difficulty if you need to exit early. Start month-to-month if you're not confident you'll stay the full year.

Henry Meds — no membership fee, one clean number

Henry Meds skips the membership entirely: the medication, visits, and shipping are one line item. Injectable semaglutide runs $297 a month month-to-month, dropping to roughly $197 on a 12-month prepay; oral compounded semaglutide starts at $249. If the dual-billing structure at Mochi or Alloy bothers you, Henry Meds is the clean alternative, you know exactly what you owe from the first month.

How do I actually get semaglutide without insurance, step by step?

• Check your plan first, even if you're fairly sure it excludes weight management. A formulary exclusion is different from a denial you can appeal, get the specific reason in writing before assuming cash-pay is your only route.
• Decide brand versus compounded. If you want the FDA-approved finished product, you're pricing NovoCare and GoodRx. If the compounded pathway is acceptable to you, you're pricing Alloy, Mochi, Fridays, or Henry Meds.
• Complete a telehealth intake. Every legitimate option above requires an actual clinical review, your health history, current medications, and a check for contraindications, before any prescription is written.
• Ask for the all-in maintenance price in writing, not just the intro rate. What you'll owe at month three or six is the number that matters, not the first-month teaser.
• Budget for extras. Some programs bill labs separately ($75-$150 is typical); ask directly rather than assuming they're bundled.
• Enroll and set a review date. Give yourself a checkpoint at three months to confirm the price, the dose, and whether the provider is still the right fit.

Wegovy vs. Ozempic without insurance — does which one you're prescribed change the price?

Yes, meaningfully, and it trips a lot of people up because both drugs are semaglutide. Wegovy carries the FDA obesity indication; Ozempic is approved for type 2 diabetes and used off-label for weight loss. That difference in approval status shapes both insurance coverage and the self-pay pricing Novo Nordisk sets for each.

• NovoCare tablet, both drugs: reportedly starts around $149/mo
• NovoCare pen, both drugs: $199/mo intro rate for the first two fills
• Wegovy pen after intro: settles at $349-$399/mo depending on dose
• Ozempic pen after intro: $349/mo at lower doses, climbing to $499/mo at the 2mg strength
• Full retail, no program: Wegovy ~$1,349/mo; Ozempic ~$900-$1,100/mo

GoodRx tracks this same split: for Wegovy, it appears to mirror NovoCare's self-pay number directly, so the practical case for using it is convenience, a local pharmacy pickup instead of NovoCare's mail-order process, at roughly the same price. For Ozempic, GoodRx runs its own independent coupon instead of mirroring anything, and it's generally the higher of the two options, so it's worth pricing both before assuming GoodRx wins by default.

The practical upshot: if your prescriber is choosing between the two purely on cost and you don't have a diabetes diagnosis, Wegovy's self-pay ladder is usually the cheaper and more defensible track, it's what the drug is actually approved to treat. Ozempic makes financial sense mainly if you do have type 2 diabetes, where insurance coverage is more reliably available in the first place.

Is compounded semaglutide a legitimate way to save money — and is it still legal in 2026?

Yes, through a narrower door than existed a couple of years ago. The FDA declared the nationwide semaglutide shortage resolved in February 2025, which ended the broad exemption that let large-scale 503B outsourcing facilities compound copies of the brand-name drug for the mass market. That kind of bulk compounding is no longer permitted.

What remains legal is the 503A individual-patient pathway: a licensed compounding pharmacy fills a prescription for one specific, named patient when a clinician documents a real clinical need. Alloy, Mochi, Fridays, and Henry Meds all operate this way today, the prescription comes from your telehealth provider, and a state-licensed 503A pharmacy mixes and ships to you specifically.

• 503A (individual-patient) compounding: still legal, this is the model every program above uses.
• 503B (outsourcing facility, bulk) compounding: on April 30, 2026 the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List entirely; the public comment period was extended and now runs through July 30, 2026, with no final rule issued as of this writing.
• What this means for you: your provider should be using a state-licensed 503A pharmacy filling an individual prescription. Ask directly which pharmacy compounds your medication.
• Compounded semaglutide is not FDA-approved as a finished product. It contains the same active peptide as Wegovy, but the FDA does not review individual compounded batches for potency or purity the way it reviews the branded drug.

Does WeightWatchers (Sequence) actually save you money on semaglutide without insurance?

It depends heavily on what you're actually buying. WeightWatchers folded its former Sequence clinic into WW Clinic (also called WW Med+), and the membership itself is priced in tiers: $49 for the first month, then $99 a month on a 3-month plan, $84 on a 6-month plan, or $74 a month if you commit to a full year, $149 a month if you'd rather stay month-to-month with no commitment. That membership buys you a licensed prescriber, labs, and a care team that specializes in navigating insurance prior authorizations for brand-name GLP-1s.

Here's the part that changes the math: the medication itself is billed separately from that membership fee, and WW Clinic prescribes FDA-approved Wegovy, not compounded semaglutide. So for a genuinely cash-pay patient with no usable coverage at all, you're paying the membership plus whatever NovoCare's self-pay rate happens to be on top, which puts the true all-in cost above what Mochi, Alloy, Fridays, or Henry Meds charge for a comparable compounded month. WW Clinic earns its keep for a different woman: one who does have some insurance in play and needs a team built specifically to fight for prior authorization and formulary coverage, not one who's decided upfront she's paying cash for everything.

What does a full year actually cost, by pathway?

• Alloy Health: $169/mo × 12 = ~$2,028/yr.
• Mochi Health: $178/mo × 12 = ~$2,136/yr.
• Fridays (annual plan): $150/mo × 12 = ~$1,800/yr, the lowest annual figure on this page.
• Henry Meds (12-month prepay): $197/mo × 12 = ~$2,364/yr.
• NovoCare Wegovy tablet (if confirmed at $149/mo): ~$1,788/yr.
• NovoCare Wegovy pen at the standard $349/mo maintenance rate: ~$4,188/yr.
• NovoCare Ozempic pen at $349-$499/mo maintenance: ~$4,188-$5,988/yr.
• WeightWatchers Clinic membership alone (12-month plan, $74/mo): ~$888/yr, before adding the separate medication cost.
• Retail Wegovy with no program: $1,349/mo × 12 = ~$16,188/yr.
• Retail Ozempic with no program: ~$900-$1,100/mo × 12 = ~$10,800-$13,200/yr.

Laid out this way, the gap between the cheapest and most expensive legitimate path exceeds $14,000 a year. Almost none of that gap is about safety or quality, it's about which door you walked through.

How to choose without insurance — red flags, and who each option actually fits

Price alone doesn't tell you which option is right. A few things to check before you hand over payment information:

• No prescription required, or a questionnaire that auto-generates one without a licensed clinician actually reviewing your history, walk away.
• Pricing far below every number on this page with no explanation of how that's possible.
• No named, verifiable, US-licensed compounding pharmacy behind the medication. Ask directly and expect a real answer.
• Marketing language like 'generic Wegovy' or 'FDA-approved compound', neither phrase accurately describes any compounded product.
• Payment requested before any medical review takes place, rather than after a clinician confirms you're actually a candidate.

On fit: if you're in perimenopause and weight gain is showing up alongside hot flashes, sleep disruption, or mood changes, Alloy's combined GLP-1 and hormone-therapy model is worth a real look before you default to a GLP-1-only platform, treating the metabolic piece in isolation from the hormonal one often means treating half the picture. If you want the cheapest possible compounded number and can commit to a year, Fridays wins on price. If you want brand-name Wegovy specifically and don't have usable insurance, NovoCare's own self-pay program is the reported floor, confirm it's live before counting on it. And if you do have some insurance coverage but need help fighting for it, WW Clinic's navigation model is built for exactly that scenario, not for a purely cash-pay decision.